FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071330 [Registered on: 25/07/2024] Trial Registered Prospectively
Last Modified On: 24/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To find the difference between Mushkakadi Gana Churna Udvartana and Triphala Gana Churna in obesity  
Scientific Title of Study   Evaluation of Comparative Efficacy of Mushkakadi Gana Udvartana Vs Triphala Gana Udvartana in the management of Obesity (Sthoulya) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kashmira Bhaidkar 
Designation  PG Scholar 
Affiliation  Datta Meghe Institute of Higher Education and Research  
Address  Room no 40 Department of Panchakarma Mahatma Gandhi Ayurveda College Hospital and Research Centre Hirapur Salod Wardha Maharashtra 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  7829813131  
Fax    
Email  kashmirabhaidkar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kashmira Bhaidkar 
Designation  PG Scholar 
Affiliation  Datta Meghe Institute of Higher Education and Research  
Address  Room no 40 Department of Panchakarma Mahatma Gandhi Ayurveda College Hospital and Research Centre Hirapur Salod Wardha Maharashtra 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  7829813131  
Fax    
Email  kashmirabhaidkar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vinod Ade  
Designation  Professor  
Affiliation  Datta Meghe Institute of Higher Education and Research  
Address  Room no 40 Department of Panchakarma Mahatma Gandhi Ayurveda College Hospital and Research Centre Hirapur Salod Wardha Maharashtra 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  9689365368  
Fax    
Email  dr.vinodade@gmail.com  
 
Source of Monetary or Material Support  
Mahatma Gandhi Ayurveda College and Research Centre Hirapur Salod Wardha 
 
Primary Sponsor  
Name  Mahatma Gandhi Ayurveda College and Research Centre Hirapur Salod Wardha 
Address  Room 40 Department of Panchakarma Mahatma Gandhi Ayurveda College and Research Centre Hirapur Salod Wardha 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kashmira Bhaidkar   Mahatma Gandhi Ayurveda College Hospital and Research Centre  Room no 40 Department of Panchakarma Mahatma Gandhi Ayurveda College Hospital and Research Centre Wardha
Wardha
MAHARASHTRA 
7829813131

kashmirabhaidkar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma Gandhi Ayurveda College Hospital and Research Centre Institutional Ethics Committee Salod Wardha   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E669||Obesity, unspecified. Ayurveda Condition: MEDOROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-udvartanam, उद्वर्तनम् (Procedure Reference: Sushruth Samhita , Procedure details: Subiect will be introduced to medicine as per scheduled. Udvartanam will be carried out using Triphala Gana for 30 to 45 minutes per day for 15 days.)
(1) Medicine Name: Triphala gana , Reference: Sushruth Samhita , Route: Topical, Dosage Form: Churna/ Powder, Dose: 250(g), Frequency: od, Duration: 15 Days
2Intervention ArmProcedure-udvartanam, उद्वर्तनम् (Procedure Reference: Sushruth Samhita , Procedure details: Subiect will be introduced to medicine as per scheduled. Udvartana will be carried out using Mushkakadi Gana for 30 to 45 minutes per day for 15 days.)
(1) Medicine Name: Mushkakadi Gana , Reference: Ashtang Hrudayam , Route: Topical, Dosage Form: Churna/ Powder, Dose: 250(g), Frequency: od, Duration: 15 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients willing to participate after signing informed consent
Patients between age group of 20-60 years of either sex
Patients having BMI greater than 30 up to 40 kg per meter square 
 
ExclusionCriteria 
Details  Known case of Diabetes mellitus Cardiovascular and Renal Disorder Drug induced Obesity Hypothyroidism PCOS PCOD and any skin ailment
Pregnant lady and Lactating mothers
Not willing to continue treatment
Any other illness developed during treatment 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Mushkakadi Gana Churna Udvartana with reduction in weight BMI skin fold thickness anthropometric measurements  15days 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Triphala Gana Churna Udvartana with reduction in weight BMI skin fold thickness   15 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The volunteer will be informed about the study protocol. Willing patients will be randomly selected as per computer generated table. Clinical research format will be prepared and validated. Prior to study approval will be taken from IEC, MGACHRC, Salod (H) Wardha and CTRI registration will be done. After selection, each patient will be assessed and selected accordingly to selection criteria. They are divided into two groups the trial is a Randomized single blind reference standard control superiority trial. It will include 17 days treatment and 16th day follow up period.

 
Close